|
|
|||
|
||||
OverviewThis is an examination of bispecific antibodies (BsAb), molecules that have two different specificities. BsAbs can be prepared which bind both to target cells (pathogens or tumours) and to toxins, enzymes or cytotoxic trigger molecules on leukocytes. The authors consider how BsAbs are prepared and used in: targeting the cytotoxity of tumours, infectious agents and infected cells; vaccine development; and targeting drugs and radioisotopes. By redirecting normal cytotoxic mechanisms or targeting other molecules and cells, BsAbs represent a potentially powerful new therapeutic tool able to focus natural physiological mechanisms in the treatment of a variety of disorders. Full Product DetailsAuthor: Michael W. FangerPublisher: Springer-Verlag Berlin and Heidelberg GmbH & Co. KG Imprint: Springer-Verlag Berlin and Heidelberg GmbH & Co. K Weight: 0.635kg ISBN: 9783540588856ISBN 10: 354058885 Pages: 161 Publication Date: April 1995 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: Out of stock The supplier is temporarily out of stock of this item. It will be ordered for you on backorder and shipped when it becomes available. Table of ContentsReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |
||||